Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

E-Poster Display

1755P - The beginning of the COVID-19 era: The perception of oncological patients (pts) in active treatment at the Brindisi and Mauriziano Hospital Oncology Departments

Date

17 Sep 2020

Session

E-Poster Display

Topics

COVID-19 and Cancer

Tumour Site

Presenters

Dario Loparco

Citation

Annals of Oncology (2020) 31 (suppl_4): S934-S973. 10.1016/annonc/annonc289

Authors

D. Loparco1, M. Di Maio2, L. Orlando1, F. Dascanio2, C. Caliolo1, G. Ignazzi2, P. Schiavone1, G. Lacidogna2, A. Quaranta1, D. Marino2, G. Del Bene1, F. Vignani2, P. Fedele1, E. Sperti2, M. Caloro1, S. Terzolo2, M. D'Amico1, A. Bellezza2, R. Comite2, S. Cinieri1

Author affiliations

  • 1 Oncology, Ospedale A. Perrino, 72100 - Brindisi/IT
  • 2 Oncologia, Azienda Ospedaliera Ordine Mauriziano di Torino, 10128 - Torino/IT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1755P

Background

The COVID-19 pandemic have had a strong logistical and psychological impact on the population. A specific attention has been devoted to the organization of activity of Oncology units and to oncological patients’ mental health conditions. In fact, oncological pts are now experiencing apprehension not only for their cancer but also for the pandemic. The aim of this research is to evaluate how the COVID-19 emergency has affected access to treatments, management of disease and the psychological impact on pts in 2 Oncology Units in Brindisi (Apulia) and Turin (Piedmont).

Methods

In a 2 week period between April and May 2020, a structured questionnaire was administered to pts in active treatment at the Day hospital (DH)/ Day Service (DS) of Oncology Dpts at Brindisi and Mauriziano Hospital. The questionnaire was anonymous, self-administered, with 5 closed-ended questions with a “yes/no” answers and 10 questions involving a modified Likert scale of 4 answers. Percentage data are analyzed for the whole series and the 2 centers separately.

Results

404 questionnaires were collected (Brindisi 202, Turin 202). The main difference involves the number of pts with relatives tested positive to SARS-CoV2 (Apulia 2% vs. Piedmont 11.4%, p=0.002). Overall, 343 pts (84,9%) referred no relevant changes in the treatment of their illness. They indicated no relevant alterations in the access to medical care (n= 362, 90%), in outpatient visits (n= 341, 84.8%), in running diagnostic exams (n= 340, 84.6%) and in drug supply (n= 365, 90.8%). 291 pts (72,4%) did not perceive a significant risk of contagion in accessing their DH/DS. Overall, pts did not believe they have received a significant reduction in assistance (n=372, 92.1%). The communication with the medical staff has been judged effective and clear (n= 374, 93%) and pts claimed it had been easy to reach the staff via phone or e-mail (n=364, 90.1%). There were no relevant differences between the 2 centers.

Conclusions

Despite the changes in the clinical management of cancer pts due to the COVID-19 emergency, our data show that most pts did not perceive any relevant difference in the management, both from an operational and relational point of view.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Saverio Cinieri.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.